chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain wasn't as intense; soreness at the injection site; muscle pain; fatigue; bone pain; got the same symptoms, but they were not as intense; shortness of breath was not as intense; tachycardia was not as intense/ wasn't tachycardic so much; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (got the same symptoms, but they were not as intense), DYSPNOEA (shortness of breath was not as intense), TACHYCARDIA (tachycardia was not as intense/ wasn't tachycardic so much), PAIN (pain wasn't as intense) and BONE PAIN (bone pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 14-Feb-2021, the patient experienced PAIN (pain wasn't as intense). In February 2021, the patient experienced VACCINATION COMPLICATION (got the same symptoms, but they were not as intense), DYSPNOEA (shortness of breath was not as intense), TACHYCARDIA (tachycardia was not as intense/ wasn't tachycardic so much), BONE PAIN (bone pain), MYALGIA (muscle pain) and FATIGUE (fatigue). In February 2021, BONE PAIN (bone pain) had resolved, MYALGIA (muscle pain) outcome was unknown. At the time of the report, VACCINATION COMPLICATION (got the same symptoms, but they were not as intense), DYSPNOEA (shortness of breath was not as intense), TACHYCARDIA (tachycardia was not as intense/ wasn't tachycardic so much), PAIN (pain wasn't as intense), VACCINATION SITE PAIN (soreness at the injection site) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not provided.  Patient took Benadryl before taking the second shot.  Treatment information was not provided   This case was linked to MOD-2021-335716 (Patient Link).
Testing positive day after testing negative; Treatment of COVID-19/Testing positive day after testing negative; Treatment of COVID-19/Testing positive day after testing negative; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 42 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: IBUPROFEN; ACETAMINOPHEN. No Known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "recovering" and all described as "Treatment of COVID-19/Testing positive day after testing negative"; DISEASE RECURRENCE (medically significant) with onset 04Sep2022 at 07:00, outcome "recovering", described as "Testing positive day after testing negative". Patient was Tested positive day after testing negative with runny nose, congestion, headache. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive, notes: Testing positive day after testing negative,(Disease recurrence). Therapeutic measures were taken as a result of drug ineffective, covid-19 with anti-viral Treatment Paxlovid from 26Aug2022 and stopped on 30Aug2022. Therapeutic measures were not taken as a result of disease recurrence.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Bleeding  Menstrual cycle came on again 1/12/21 with cramping, dizziness, just got off menstrual cycle last week.   Narrative:
Diaphoretic and tachycardic within 5 minutes of receiving vaccine. Rate up to 151 with BP 146/82. Rate would go down after 5 minutes sitting quietly and then return to 150. Back down and then 15 min later, up. gave 25 mg of po benadryl at 11:30 am. This continued and 911 called. Paramedics assessed. Patient brought to ed for additional monitoring and assessment in private car. D/C'd at 2:30pm with no other interventions.
This case was reported by a nurse via sales rep and described the occurrence of adverse reaction in a patient who received Influenza vaccine Quadrivalent unspecified season. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced adverse reaction. On an unknown date, the outcome of the adverse reaction was unknown. It was unknown if the reporter considered the adverse reaction to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. The nurse practitioner and a student were having a conversation about the patient in the office and the student said that the patient had an adverse reaction to a flu vaccine. No other information was available. The reporting representative did not recall the exact date that she first became aware of the event, but it was sometime last week from the date of reporting.
2/17/2021 He was transferred to the hospital because he was having respiratory problems and died in the hospital due to respiratory arrest.
Patient encountered leaving vaccination center. Mentioned to the  she had pain now in her left arm, and it was going into her hand.  brought patient back into the center.  Evaluation per NP and EMS.  CMST of L hand intact.  Able to feel all stimuli and move hand. Denied numbness and tingling in L hand or arm. No focal neurological findings Applied cold pack to patient's injection site.  Symptoms improved quickly.  Symptoms resolved within 10 minutes.  Accompanied by her husband. Answered all questions appropriately.  Discharged home 5:20 pm
This spontaneous report was received from a nurse practitioner refers to a 60 year old female patient, who did not have chickenpox. There was no information about patient's concurrent conditions and concomitant therapy provided. On an unknown date, also reported as "20 years ago, in the early 1990's" the patient was vaccinated with (Merck) VARIVAX (lot#, expiration date, dose, were not reported) subcutaneously, the reporting nurse stated that it was possibly (but she was not sure) patient's 2 dose series. On 31-JUL-2015, the patient had titers drawn, which showed negative to varicella. There were no adverse effects beyond negative titers. The outcome of the event was unknown. The relatedness between the event and (Merck) VARIVAX was not reported. Additional information has been requested.
This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received 4th dose of KINRIX (batch number 9AB77, expiry date 19th October 2015). On an unknown date, the patient received KINRIX. On an unknown date, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional information: a 12 month old was inadvertently given KINRIX as the 4th dose of DTaP series.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided by the reporter. No treatment medication was provided.  The patient was monitored for at least 15 minutes after the injection with no adverse events. reported.
Rash; This case was reported by a pharmacist via call center representative and described the occurrence of itchy rash in a 73-year-old male patient who received Herpes zoster (Shingrix) (batch number 3FD3N, expiry date 9th July 2021) for prophylaxis.   On 11th April 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a year after receiving Shingrix, the patient experienced itchy rash. On an unknown date, the outcome of the itchy rash was recovered/resolved.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the right arm. After vaccination with Shingrix, the patient experienced rash to the upper body. The patient did not think it was hives. The patient had bothersome itching for a couple days, but the rash lasted about 7 days before it cleared up. The event start date was unknown. No further details were provided.
Severe headache, moderate body aches (all over), touch sensitivity of skin (clothes moving on my skin or someone touching me hurt), fatigue, low grade fever.  Moderate head pressure for 2 weeks following immunization. Moderate fatigue for 1 and 1/2 weeks following immunization.
Information has been received from a registered nurse concerning a 23 year old female with a history of depression who on 03-JUL-2007 was vaccinated with a first dose of Gardasil (lot # 658100/0525U) 0.5mL IM. Concomitant therapy included LEXAPRO. On 03-JUL-2007 the patient experienced lightheadedness immediately after vaccination with Gardasil. the patient then fainted and hit her head. She subsequently complained of double vision. Medical attention was sought. The patient was transported to the local emergency room by ambulance. The nurse reported that she is unaware of the details of the evaluation in the emergency room but the patient was not admitted to the hospital. At the time of reporting it is unknown if the patient has recovered. No further information is available. Additional information has been requested.  Additional information was received. On an unspecified date the patient recovered and was discharged from the emergency room. Additional information is not expected.
Chills, major body aches, nausea, massive headache, tiredness from 4am to 3:30 pm 1/21/21. Around 11 am, I was get to find some stregth to get out of bed and take some Ibuprofen.After that time minor fatigue, minor muscle ache and headache.  In the morning of 1/22/21 about 7am feeling 50% better.  About noon about 90% better.
Weak, heavy heart, in bed for 7 days, exhaustion. Swelling in feet. Was referred to a cardiologist.
I had a cold with a cough, runny stuffy nose. The symptoms lasted for over 2 weeks. I completed a home test for COVID-19 as well as a PCR test which was negative. I was taking over the counter cough medication as well as a prescribed cough medication. The symptoms finally resolved, and I have completely recovered.
STARTING AROUND NOON ON 12/15/21 SEVERE HEADACHE, FEVER, NAUSEA, SHAKING, SENSITIVE TO TOUCH, TINGLING IN BOTH HANDS AND FINGERS
Had the COVID arm with swelling and big red rash. Itching at injection site, fever, heachache, chills and body ache.
This spontaneous report as received from a physician refers to a 15 year old male patient with anxiety. The patient's medical history included rash. On 09-AUG-2017 the patient was vaccinated with GARDASIL 9, intramuscular for prophylaxis. In August 2017 the patient experienced nausea, abdominal pain and vomiting. The outcome of abdominal pain, vomiting and nausea was reported as not recovered/not resolved.
Patient received FLUCELVAX vaccination for influenza for 2015-2016 year and experience paraesthesia in the form of numbness, tingling in left arm and leg a few hours after vaccination, but was transient and didn't require further medical care.
Local erythema approximately 7 x 5cm, swelling pain, some induration - resolved over approximately 4 days.
developed fever 100 F at midnight and fever of 102.5 F at 4 am.  Assoc with body aches, HA and decrease sense of taste and smell
Rash appeared on chest on 2/20/21 after first shot on 2/11/21. Consulted with dermatologist .  Prescribed Triamcinolone. After second shot on 3/4/21 rash moved to whole body, from head to knees two days later.  (Not on face or hands).  It was inflamed dots like measles or chicken pox with extreme itching.   Returned to Dr.  He took a biopsy and prescribed Clobetasol for head.   Rash and itching increased, with welts in head and spots over body.   March 18- Dr.administered a cortisone shot (60 mg.).  Relief for 4 hours and then rash and itching increased. March 25- Dr. administered a second cortisone shot.  No change March 26- Saw  rheumatology.  She prescribed prednisone 10mg twice daily. famotidine, and zyrtec (instead of Allegra).  Itching and intensity of the rash (red spots) have decreased.
Information has been received from the Freedom of Information Act regarding a female (age not provided) who on 27Jan2010 was vaccinated with MMRII. As the result of this vaccine the patient developed idiopathic thrombocytopenia purpura (no date reported). Outcome of the event was not reported. It was noted the patient's immunization records were sent to CDC on 26May2010. Upon internal medical review, idiopathic thrombocytopenic purpura was considered medically significant. Additional information has been requested.
Mouth blisters, heavy chest, runny noise, muscle pain, throat swollen, thick tongue.
Inflammation to left ankle and both knees to the point that I was not able to walk.  I have gout attacks but this was nothing like a gout attack.   I took gout medication and did not help. only time and rest allowed the ankle to go down.  I am schedule to see another doctor to check if the inflammation has anything to do with blood circulation, heart issue, both issue new to me
Fever, chills on day off. Next day extreme lethargy to the point of not being able to stay awake for more than an hour. First round of vaccine was Moderna
jaw pain/ had little pains in his jaw; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 56 year-old male patient received bnt162b2 (BNT162B2), administration date 07Apr2021 16:20 (Batch/Lot number: unknown) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Heart attack", start date: Dec2017 (unspecified if ongoing), notes: he did have a heart attack 3-4 years ago (Heart attack (From: Dec 2017 To: Unspecified). Concomitant medication(s) included: IMDUR taken for myocardial infarction; LISINOPRIL taken for myocardial infarction; ATORVASTATIN taken for myocardial infarction; CARVEDILOL taken for myocardial infarction. The following information was reported: PAIN IN JAW (non-serious) with onset Apr2021, outcome "not recovered", described as "jaw pain/ had little pains in his jaw". Therapeutic measures were not taken as a result of pain in jaw.  Additional information: He experienced jaw pain "2 or 3 days" after he had his first shot (07Apr2021) of Pfizer BioNTech Covid-19 Vaccine and experienced shoulder and chest pain 4-5 days after his second shot (30Apr2021). He had a heart attack 3 and a half years ago, and he came across 3 incidents of heart attack in a study in (Privacy) website. Possible AE Duplicate, he states that he talked to someone from Pfizer who got this information however he is unsure if it is someone from (Privacy). Age: 56 / Gender: Male. Description of complaint: Caller states he had the Pfizer Covid vaccine and states he is unsure of the state of when he had the 1st dose of the vaccine but it was on a Wednesday and was three weeks prior to his 2nd dose and the 2nd dose was administered on 30Apr2021. States he did have a heart attack 3-4 years ago and got the 1st shot of the Pfizer COVID vaccine and did not think about it but then had little pains in his jaw and after the 2nd dose began having pressure across his chest. States he got the 2nd dose of the Pfizer COVID Vaccine a week ago on 30Apr2021 and that was about 10-11 days ago and he began having pressure across his chest and looked it up and it said during the trials there were three heart attack type things reported and he wanted to find out if Pfizer had narrowed down that information to a particular medication or it it happened almost right away after the vaccine or if it was a few weeks later. Caller states he takes four medications for his history of heart attack and has been taking them for 3-4 years since his heart attack and his heart attack was in Dec2017.  States he takes Imdur 60mg once per day by mouth and initially states he cannot remember the names of the others but then states he takes Lisinopril 10mg once per day by mouth, takes Atorvastatin 40mg once per day by mouth and also takes Carvedilol 6.25mg and takes two per day of one in the morning and one in the evening.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Headache Arm pain General Muscle pain Fatigue I peed a lot (1week) dizziness
received flu shot with no incident + left vaccination room. Within a minute, mother returned to immunization room to report son had fainted. RPh followed mother to waiting area where patient lying on ground but alert. Felt dizzy chose to lie on floor + drink water until felt recovered enough to ( change about 20 min) leave w/mom
This spontaneous report as received from a 60 year old female nurse regarding herself. The patient's concurrent conditions included diabetes and high blood pressure. On 20-SEP-2015, the patient was vaccinated with 0.65 ml of ZOSTAVAX subcutaneously for prevention of shingles. The patient also received a dose of unspecified influenza virus vaccine. Concomitant medications included many unspecified medications. On 23-SEP-2015, the patient started to develop a rash with little bumps on her left arm around the injection site which was described as oval in shape measuring 12 centimeter (cm) long and 5 cm wide. The rash was reported as red in color and warm to touch. There was a larger and lighter color around the rash which had begun to subside on 24-SEP-2015 but was yet sore to touch. The patient felt feverish as though she was falling sick. The Varicella-zoster virus packet was declined. The patient did not sought medical attention and no treatment was provided for the events. The outcome of falling sick, injection site pain and feeling feverish was unknown. The outcome of the injection site reactions reported for the main rash were recovering at the time of this report. The relatedness of the events with suspect therapies was not reported. Additional information has been requested.
Fever, body pains, headache, chills, soreness at injection site and full right arm, back pain
I had sore throat for a couple of days. Sinus congestion and was very stiffy. I had loss of energy on 6/21/2022. The symptoms became worse and took a COVID-19 test which came back negative. I had a fever of 101.0 and could not get out of bed. Took another COVID-19 test and came back positive. I called the doctor and was prescribe me a Z-pack, Vitamin B, and Vitamin C.
Redness at injection site, sore arm upset stomach--on first shot has chills and fever.
States he had gone to college & upon leaving building experience sudden dizziness & H/A& malaise, lips numb for short time; happened 45 minutes to 1 hr after receiving MMR, dizziness last for 5 hour (7 pm); Frontal headache continued past 10:30 8-10 hr when he went to sleep; Next day feels ok.
This spontaneous report as received from a licensed vocational nurse refers to a patient of unknown age and gender. On 09-DEC-2014 the patient was vaccinated with GARDASIL (lot # K005881, expiry date: 14-JUL-2017, dose, units, route of administration and anatomical location were not reported) that had been through a temperature excursion on that day and possibly a past temperature excursion. This is one of several reports from the same reporter. Additional information has been requested.
Patient began having edema, erythema, and pain at injection site 24 hours after injection. Area continued to swell over next 24 hours.
-Pain at injection site, right away, 48 hour. -Fever 101 started about 12 hours after shot and lasted about 14 hours. -muscle aches and pains started about the same time of the fever and lasted the same amount of time.  It hurt to move.
Tested positive for COVID-19 with a home test two months after 5th vaccine; Called Primary Doctor and was prescribed Paxlovid; Eight days later took another COVID-19 test and was negative; A few days later started feeling bad again, tested Positive for COVID-19 again; Rested and isolated.
C/O body aches, dizziness, palpitations, dizziness, nausea, chills, blurred vision, & SOB.  Up in chair with legs elevated.  BP 129/90, pulse 71, & O2 sat is 97% on RA. Stayed for additional Observation & consumed water. Symptoms subsided prior to discharge, Awake, Alert, & oriented. Encouraged to go to ER, Urgent Care, or F/U with primary physician. Verbalized understanding.
pharmacy intern accidentally stuck himself with the easy point needle in left as he was trying to depress the safety device, after vaccinating the patient
began elevated fever, listless, excessive drowsiness clingy; gave pt APAP @ 12noon; 645PM temp was 103.9;
This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. On 10-AUG-2017, the patient was vaccinated with an expired dose of ZOSTAVAX lot number M035146, expiration date 10-AUG-2017, for prophylaxis. Concomitant therapies included an sterile diluent lot number M044950, expiration date 30-MAY-2019. No symptoms were reported.
arm pain; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 59 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 08:30 (Lot number: ER8733) at the age of 59 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "IBS" (unspecified if ongoing); "arthritis" (unspecified if ongoing); "Allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 29Mar2021, outcome "recovered" (2021), described as "arm pain". Therapeutic measures were not taken as a result of pain in extremity.  Additional Information: No any other vaccine in four weeks. Shot 1 - arm pain - radiation up the back to neck. Last 6 hours. Shot 2 - 12- 48 hours - arm pain, foggy brain, tiredness. 3-7 days - lymph node swelling under left arm. There was no covid prior vaccination. Did not tested for covid post vaccination.  No follow-up attempts are possible. No further information is expected.
severe thrombocytopenia, ITP. platelet count of 0. initiating treatment w/ dexamethasone and IVIG.
THIS CHILD RECEIVED 0.25 ML OF FLU VACCINE INSTEAD OF 0.5 ML OF FLU VACCINE.
Body aches and pains, muscle pain, sharp bone pain in legs, chills, headache , and fatigue